Companies / Poland
Bioton Acquires Stake In Ukraine Insulin Maker
June 2006 | FDI AlertPolish firm Bioton has purchased a 21.1% stake in Indar - Ukraine's only local producer of insulin - for PLN10.1mn (US$3.3mn). Indar has a 70% market share in its domestic market and posted sales of PLN50mn (US$16.3mn) last
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.



